RESUMO
Cyanobacterial blooms appear more strongly, constantly and globally, yet the positive effect of surface solar ultraviolet radiation (UV) on cyanobacterial bloom in natural freshwater habitats is largely ignored. Here in-situ and laboratory studies were jointly designed to probe the mechanism of cyanobacterial bloom promoted by solar UV light. The results showed that solar UV light is a key trigger factor for the accumulation of total phosphorus, dissolved inorganic phosphorus and polyphosphate (polyP) in blooming cyanobacterial cells. The increase of UV dose induces polyP accumulation to result in the excessive phosphorus uptake of blooming cyanobacteria, which provides sufficient phosphorus for cyanobacterial growth in suitable environment. Solar UV light also can promote the contents of phycocyanin, allophycocyanin, and phycoerythrin, producing sufficient ATP by photosynthesis for polyP synthesis in cyanobacterial cells in lake enviroment. The frequent variations of UV irradiance exposure prompts cyanobacteria to absorb excessive phosphorus from suspended solid or sediment. Cyanobacterial intracellular phosphorus is accumulated for their growth. UV light promotes polyP accumulation in blooming cyanobacterial cells to avoid damage. The adsorption amount of phosphorus increases for exuberant growth and then more surface blooming cyanobacteria are exposed to UV light to absorb ample phosphorus. Thus, the positive feedback occurs in lake water bodies with abundant phosphorus. This amplified cycle of cyanobacterial density and phosphorus due to solar UV light in eutrophic water bodies is analogous to a triode to amplify visible photosynthesis by UV light as a base electric current in the energy flow process in lake environment, therefore, "Cyanobacterial Phosphorus Assimilation Ultraviolet Effect" is used to describe this phenomenon. A new explanation is provided for the continuing proliferating mechanism of cyanobacterial bloom. Besides, a new perspective appears on the outbreak of cyanobacterial blooms in natural eutrophic lake water bodies worldwide.
Assuntos
Cianobactérias , Raios Ultravioleta , China , Eutrofização , Lagos/microbiologia , Fósforo/análise , Polifosfatos , ÁguaRESUMO
Research in the last few years has revealed that leukaemic cells can remodel the bone marrow niche into a permissive environment favouring leukaemic stem cell expansion. Tumour-associated macrophages (TAMs) are prominent components of the tumour microenvironment and play an important role in the onset and progression of solid tumours. However, little is known about their role in the development of acute lymphoblastic leukaemia (ALL). Using a unique mouse model of T-ALL induced by injection of EL4 T-cell lymphoma cells to syngeneic C57BL/6 mice, we report herein that ALL leads to the invasion of leukaemia-associated monocyte-derived cells (LAMs) into the bone marrow and spleen of T-ALL mice. Furthermore, we found that leukaemia cells could polarize bone marrow-derived macrophages (BMDMs) into LAMs. In turn, LAMs were able to protect leukaemia cells from drug-induced apoptosis in vitro. Therapies targeted against the TAMs by inhibiting colony stimulating factor-1 receptor (CSF-1R) have emerged as a promising approach for cancer treatment. In this study, we demonstrate that CSF-1R inhibition inhibits the viability of BMDMs, blocks LAMs polarization and reduces the abundance of LAMs in T-ALL mice. In vivo, combination treatment of CSF-1R inhibitor and vincristine (VCR) dramatically increased the survival of T-ALL mice and delayed leukaemia progression compared with VCR monotherapy. Finally, these data reinforce the role of microenvironments in leukaemia and suggest that macrophages are a potential target for the development of novel therapeutic strategies in T-ALL.
Assuntos
Regulação Leucêmica da Expressão Gênica , Leucemia/metabolismo , Macrófagos/metabolismo , Receptores de Fator Estimulador das Colônias de Granulócitos e Macrófagos/antagonistas & inibidores , Receptores de Fator Estimulador das Colônias de Granulócitos e Macrófagos/metabolismo , Animais , Apoptose , Linhagem Celular Tumoral , Proliferação de Células , Progressão da Doença , Feminino , Camundongos , Camundongos Endogâmicos C57BL , Transdução de Sinais , Microambiente Tumoral , Vincristina/farmacologiaRESUMO
INTRODUCTION: Sarcomatoid hepatocellular carcinoma (SHC) is a rare subtype of liver cancer with extremely poor prognosis. This study aimed to identify the prognostic factors and develop an exclusive and efficient nomogram to predict cancer-specific survival (CSS) for SHC. METHODS: The data on patients diagnosed with SHC from January 1973 to December 2015 were retrieved from the Surveillance, Epidemiology, and End Results (SEER) database, and these patients were included as the training cohort. Least absolute shrinkage and selection operator (LASSO) and Cox proportional hazards regression analyses were used to identify the prognostic risk factors and construct a nomogram. The predictive accuracy and discriminative ability of the nomogram were determined using concordance index (C-index), calibration curve, and receiver operating characteristic (ROC) curve. Decision curve analysis (DCA) was used to compare the clinical benefits of the prognostic evaluation model (PEM) with that of the American Joint Committee on Cancer (AJCC) staging system. The results were validated with an external validation cohort. RESULTS: In total, 116 patients with SHC were included in the training cohort. Multivariate Cox analysis revealed M stage (distant metastasis), primary tumor surgery, and chemotherapy to be associated with CSS, and along with tumor size, an integrated PEM was constructed. A calibration curve for the probability of survival showed good agreement between the nomogram and actual observation. The C-index value of the nomogram for predicting CSS and AJCC was 0.853 and 0.649, respectively. In the validation cohort, the C-index value of the PEM discrimination was better than that of the Barcelona Clinic Liver Cancer (BCLC) staging system, CLIP score, and Okuda staging system, and no statistical difference was observed with eighth edition of the AJCC staging system and Izumi staging system. CONCLUSION: The proposed four-factor nomogram of PEM could accurately predict the prognosis of SHC and could be used in clinical practice.
Assuntos
Carcinoma Hepatocelular/mortalidade , Previsões/métodos , Neoplasias Hepáticas/mortalidade , Estadiamento de Neoplasias/mortalidade , Nomogramas , Prognóstico , Reprodutibilidade dos Testes , Idoso , Carcinoma Hepatocelular/fisiopatologia , Estudos de Coortes , Feminino , Humanos , Neoplasias Hepáticas/fisiopatologia , Masculino , Pessoa de Meia-Idade , Curva ROC , Fatores de Risco , Taxa de Sobrevida , Estados Unidos/epidemiologiaRESUMO
Imatinib mesylate (IM) is the first-line treatment for Philadelphia (Ph) chromosomal positive leukemia by inhibiting phosphorylation of substrates via binding to the ABL kinase domain. Because of the drug resistance, side effects and the high cost of IM, it is necessary to find anti-cancer drugs with relatively low toxicity and cost, and enhanced efficacy, such as traditional Chinese medicines (TCMs). As one of TCMs, Huai Qi Huang (HQH) was chosen to treat BV173 and K562 cells. Various concentrations of HQH were added to cells for 24-72 h. Co-treatment of HQH and trametinib, an MEK inhibitor, was used to verify the synergistic effects on cell viability and apoptosis. Knockdown and overexpression of mitogen-activated protein kinase kinase 4 (MEK4) were implemented to demonstrate the role of MEK in cell apoptosis. Cell viability and apoptosis were measured by cell counting kit-8 assay (CCK8) and flow cytometry, respectively. Western blotting and real-time quantitative PCR (RT-qPCR) were used to assess protein and mRNA expression levels, respectively. The results showed that HQH inhibited survival and promoted apoptosis of BV173 and K562 cells in a dose-dependent manner, accompanied with down-regulation of PRKCH mRNA as well as CRAF, MEK4, phospho-ERK (pERK) and BCL2 proteins, and up-regulation of cleaved caspase3 protein. Co-treatment of HQH and trametinib had a synergistic effect on inhibiting survival and promoting apoptosis. MEK4 knockdown increased apoptosis, and had a synergistic effect with HQH. In contrast, MEK4 overexpression decreased apoptosis, and had the opposite effect with HQH. Collectively, the results of this study may identify a therapeutic mechanism of HQH on promoting apoptosis, and provide a potential option for treatment of Ph+ leukemia.
Assuntos
Regulação para Baixo , Medicamentos de Ervas Chinesas/farmacologia , Leucemia Mielogênica Crônica BCR-ABL Positiva/metabolismo , Proteína Quinase C/metabolismo , Piridonas/farmacologia , Pirimidinonas/farmacologia , Linhagem Celular Tumoral , Proliferação de Células/efeitos dos fármacos , Sobrevivência Celular/efeitos dos fármacos , Relação Dose-Resposta a Droga , Sinergismo Farmacológico , Regulação Neoplásica da Expressão Gênica/efeitos dos fármacos , Humanos , Células K562 , Leucemia Mielogênica Crônica BCR-ABL Positiva/tratamento farmacológico , Leucemia Mielogênica Crônica BCR-ABL Positiva/genética , Sistema de Sinalização das MAP Quinases/efeitos dos fármacos , Proteína Quinase C/genéticaAssuntos
Anemia Diseritropoética Congênita , Glicoproteínas , Mutação , Síndromes Mielodisplásicas , Proteínas Nucleares , Anemia Diseritropoética Congênita/diagnóstico , Anemia Diseritropoética Congênita/genética , Anemia Diseritropoética Congênita/metabolismo , Pré-Escolar , Diagnóstico Diferencial , Glicoproteínas/genética , Glicoproteínas/metabolismo , Humanos , Masculino , Síndromes Mielodisplásicas/diagnóstico , Síndromes Mielodisplásicas/genética , Síndromes Mielodisplásicas/metabolismo , Proteínas Nucleares/genética , Proteínas Nucleares/metabolismoRESUMO
Biosynthesis of plant seed oil is accomplished through the coordinate action of multiple enzymes in multiple subcellular compartments. Fatty acid (FA) has to be transported from plastid to endoplasmic reticulum (ER) for TAG synthesis. However, the role of plastid FA transportation during seed oil accumulation has not been evaluated. AtFAX1 (Arabidopsis fatty acid export1) mediated the FA export from plastid. In this study, we overexpressed AtFAX1 under the control of a seed specific promoter in Arabidopsis. The resultant overexpression lines (OEs) produced seeds which contained 21-33% more oil and 24-30% more protein per seed than those of the wild type (WT). The increased oil content was probably because of the enhanced FA and TAG synthetic activity. The seed size and weight were both increased accordingly. In addition, the seed number per silique and silique number per plant had no changes in transgenic plants. Taken together, our results demonstrated that seed specific overexpression of AtFAX1 could promote oil accumulation in Arabidopsis seeds and manipulating FA transportation is a feasible strategy for increasing the seed oil content.
Assuntos
Proteínas de Arabidopsis/genética , Arabidopsis/metabolismo , Proteínas de Membrana/genética , Óleos de Plantas/metabolismo , Sementes/metabolismo , Albuminas 2S de Plantas/genética , Arabidopsis/genética , Proteínas de Arabidopsis/metabolismo , Vias Biossintéticas/genética , Ácidos Graxos/metabolismo , Regulação da Expressão Gênica de Plantas , Proteínas de Membrana/metabolismo , Tamanho do Órgão , Especificidade de Órgãos , Fenótipo , Plantas Geneticamente Modificadas , Regiões Promotoras Genéticas/genética , Açúcares/metabolismo , Triglicerídeos/biossínteseRESUMO
A novel type I ribosome-inactivating protein (RIP), designated as curcin C, was purified from Jatropha curcas, an important feedback source of bio-fuel. Molecular mass and isoelectric point of curcin C were 31.398 kDa and 7.12 as detected by MALTI-TOF assay and capillary electrophoresis assay, respectively. N-terminal sequence and LC-MS/MS analyses confirmed that curcin C is a type I RIP having high homology, but not the exactly the same with curcin, another type 1 RIP isolated from the endosperm of J. curcas. It exhibited N-glycosidase activity and in vitro translation inhibition activity. Moreover, curcin C displayed a strong selectively anti-tumor activity on human cancer cells. Its cytotoxicity against osteosarcoma cell line U20S is even higher than that of Paclitaxel with IC50 of 0.019 µM. Purification and identification of curcin C not only suggested its potential in natural anticancer drug development, but also provide chance to understanding different cytotoxic action among different RIPs.